Mackay et al., 1990 - Google Patents
Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinasesMackay et al., 1990
- Document ID
- 6537422770548607394
- Author
- Mackay A
- Corbitt R
- Hartzler J
- Thorgeirsson U
- Publication year
- Publication venue
- Cancer research
External Links
Snippet
Current hypotheses suggest that both the plasmin system and metalloproteinases are involved in tumor invasion of basement membrane. In this study, we demonstrate that plasmin can directly degrade native and denatured type IV collagen in solution as well as in …
- 108010042086 Collagen Type IV 0 title abstract description 76
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mackay et al. | Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases | |
Ochieng et al. | Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and-9 | |
Knudsen et al. | Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. | |
Chintala et al. | Matrix metalloproteinases and their biological function in human gliomas | |
Rodriguez et al. | Regulation of invasion of epithelial ovarian cancer by transforming growth factor-β | |
Kobayashi et al. | Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). | |
Ellerbroek et al. | Membrane associated matrix metalloproteinases in metastasis | |
Davies et al. | Proteinases and glomerular matrix turnover | |
Vater et al. | Inhibitor of human collagenase from cultures of human tendon. | |
Rao et al. | Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas | |
Desriviéres et al. | Activation of the 92 kDa type IV collagenase by tissue kallikrein | |
Masure et al. | Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate | |
Martin et al. | Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor | |
Hornebeck et al. | Proteolyzed matrix as a template for the regulation of tumor progression | |
Dalet-Fumeron et al. | In vitro activation of pro-cathepsin B by three serine proteinases: leucocyte elastase, cathepsin G, and the urokinase-type plasminogen activator | |
EP1071704B1 (en) | Novel matrix metalloproteinase inhibitors and down-regulators | |
Bachmeier et al. | Human Keratinocyte Cell Lines Differ in the Expression of the Collagenolytic Matrix Metallo-proteinases-1,-8, and-13 and of TIMP-1 | |
Tanney et al. | Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis | |
Yamaguchi et al. | Characterization of a cathepsin L-like enzyme secreted from human pancreatic cancer cell line HPC-YP | |
Mueller | Different roles for plasminogen activators and metalloproteinases in melanoma metastasis | |
Fujii et al. | Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors | |
Rao et al. | Partial characterization of matrix-associated serine protease inhibitors from human skin cells | |
Gold et al. | Localization of the ceavage sites on fibronectin following digestion by urokinase | |
Baumann et al. | Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes | |
Azuma et al. | Role of plasminogen activators, metalloproteinases and the tissue inhibitor of metalloproteinase‐1 in the metastatic process of human salivary‐gland adenocarcinoma cells |